Chugai Pharmaceutical Ownership

Pink Sheets . USA . 
Stock . Chugai Pharmaceutical Co
CHGCF Stock  USD 46.34  5.27  12.83%   
Chugai Pharmaceutical holds a total of 1.64 Billion outstanding shares. Chugai Pharmaceutical Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Chugai Pharmaceutical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Chugai Pharmaceutical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chugai Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Chugai Pink Sheet Ownership Analysis

About 60.0% of the company shares are held by company insiders. The book value of Chugai Pharmaceutical was currently reported as 865.88. The company last dividend was issued on the 29th of June 2023. Chugai Pharmaceutical had 3:1 split on the 29th of June 2020. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.The quote for Chugai Pharmaceutical Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Chugai Pharmaceutical Co please contact the company at 81 3 3281 6611 or go to https://www.chugai-pharm.co.jp.

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Chugai Pink Sheet

Chugai Pharmaceutical financial ratios help investors to determine whether Chugai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chugai with respect to the benefits of owning Chugai Pharmaceutical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY